STAT3 restricts prostate cancer metastasis and antiandrogen resistance by controlling LKB1/CREB signaling pathway
Pencik, J.; Philippe, C.; Schlederer, M.; Pecoraro, M.; Grund-Groeschke, S.; Li, W. J.; Tracz, A.; Heidegger, I.; Lagger, S.; Trachtova, K.; Oberhuber, M.; Heitzer, E.; Osman, O.; Neubauer, H. A.; Wingelhofer, B.; Orlova, A.; Witzeneder, N.; Dillinger, T.; Redl, E.; Greiner, G.; D'Andrea, D.; Oestman, J. R.; Tangermann, S.; Hermanova, I.; Schaefer, G.; Varady, A.; Horvath, J.; Stoiber, D.; Malcolm, T. I.; Turner, S. D.; Parkes, E. E.; Hantusch, B.; Egger, G.; Rose-John, S.; Poli, V.; Jain, S.; Armstrong, C. W. D.; Hoermann, G.; Goffin, V.; Aberger, F.; Moriggl, R.; Carracedo, A.; McKinney, C.;
Show abstract
Prostate cancer (PCa) lethality is driven by its progression to a metastatic castration-resistant state, yet the signaling mechanisms underlying metastatic spread remain unknown. Here we show that STAT3 converges with the LKB1/mTORC1 and CREB to control metastatic disease in PCa mouse models. Unexpectedly, STAT3 was found to be upregulated in diabetic PCa patients undergoing metformin therapy with a concomitant reduction in mTORC1 expression. In preclinical mouse models of PCa, genetic ablation or activation of STAT3 had opposing effects on LKB1/AMPK/mTORC1- dependent tumorigenesis. Using genetic and pharmacological approaches, we identified LKB1 as a direct STAT3 target while repressing CREB. Furthermore, PCa patients with high CREB expression had inferior clinical outcome with significantly increased risk of disease and metastatic recurrence. We observe that castration state lowers STAT3 abundance and increases AR and CREB levels, leading to castration-resistant PCa (CRPC). Our findings revealed that STAT3 controls mTORC1 and CREB in metastatic disease, suggesting CREB as a promising target for lethal CRPC.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer 97%
- A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer 96%
- Disassembly of hemidesmosomes promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin into focal adhesions 96%
Similar papers in this journal
- Role of Specialized mSWI/SNF Complexes in Prostate Cancer Lineage Plasticity 98%
- Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer 96%
- The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact 96%
Similar papers in this journal
Similar papers in this journal
- Androgen receptor inhibition induces metabolic reprogramming and increased reliance on oxidative mitochondrial metabolism in prostate cancer 96%
- Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer 96%
- ECM-free patient-derived organoids preserve diverse prostate cancer lineages and uncover in vitro-enriched cell types 96%
Similar papers in this journal
- RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer 94%
- An in vivo screen identifies NAT10 as a master regulator of brain metastasis 93%
- Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.